@FedericaSerino @giuliamasiero3 @a_sorropago @evetosca @MrcTsl @AliceBen_90 @Bellamoli_M @tonyobrowno @cescobruno @buccheri_dario @Iginio_Colaiori @PierluigiDemo @VincenzoF92

🔥Great session on mechanical cardiac support in high-risk PCI!🫀 Selection of patients, adequate planning and timing are the key to success✌️ @sicigise #highriskPCI #Impella #MCS

https://t.co/PHecW1xdhj

Figure depicting atypical ECG features of RBBB and LBBB that are suggestive of ventricular tachycardia @ECGTalk @adribaran @DrFerminGarcia @JonPicciniSr @rafavidalperez @LluisMont2 @DrJasonAndrade @EM_RESUS @SergioPinski @DoctorPhillEP @SABOURETCardio @EladAnter @iamritu #Heart

Updated guidelines and expert consensus documents in Europe and the United States are now relatively aligned with respect to recommendations for antithrombotic therapy in patients with atrial fibrillation undergoing PCI. https://t.co/2VzzYiywJd

“It is difficult to be productive at the best of times, let alone during a global crisis. So if you feel like you are failing because you aren’t “productive enough”, stop lying to yourself.” @kaleybrauer #research #postdocs https://t.co/GZyzsCHXHl

😁

#TrickOrTweet For my fellow #cardiotwitter nerds 👻 @DrMarthaGulati @mmamas1973 @hvanspall @HeartOTXHeartMD @wordfinga @wayounihan @djc795 @iamritu @dmitripapa @BethFratesMD @DBelardoMD @willsuh76 @SVRaoMD @JGrapsa @mirvatalasnag @SABOURETCardio @AnastasiaSMihai @fischman_david

Treating with broad spectrum antibiotics without sending cultures first #stewardmeme

Congratulations, @DFCapodanno! This is an important document for the field of #cardiology. Thanks for including me with this great group. @DLBHATTMD @CMichaelGibson @vlgmrc @mwkrucoff @Urphi @mc_morice @Drroxmehran @SVRaoMD #cardiotwitter #clinicaltrials

Directly from the @escardio guidelines for atrial fibrillation, yet another flow chart on dual or triple therapy, which seems to say "do what you want, but do it with science and conscience" (and a bit of aspirin). #ESCCongress https://t.co/2kKFhMt7Xp

Seems like yet another meta-analysis of DAT vs TAT for PCI patients with AF... and probably it is, but ours is full optional and, more importantly, we had fun in doing it. @DLBHATTMD @CMichaelGibson @RenatoDLopes1 @Drroxmehran @marcodimaio88 @AGrecoMD https://t.co/8Pl9ikemMt

Congratulations to @DFCapodanno on being newly appointed as Editor-in-Chief of EuroIntervention. He succeeds the co-founder of the Journal, Patrick W. Serruys! (effective as of 1 January 2020) 👏👏 https://t.co/YqzTz7eIJy

Why P2Y12 inhibitors de-escalation could not be an optimal strategy in diabetic ACS patients. Reasons in one figure 😎

If you want to get bored reading a review on switching P2Y12 inhibitors and if you want some indications on how to do it 😎 https://t.co/T8JLxuctvA

Calcified lesions? No problem! Check out this interventional tool list for #PCI of calcified coronary lesions in #JACCINT. https://t.co/U1Jmg6Nayd

https://t.co/tOzeFoslqs

#JACC State-of-the-Art Review: Learn the best approach for managing antithrombotic therapy in #AFib patients undergoing #PCI. https://t.co/VSmv7ycDJZ @UFMedicineJax @DFCapodanno

Before heading out of the cathlab for the summer holidays, join our next #EIJCardioChat! We'll discuss the #EAPCI consensus on the Clinical use of intracoronary imaging. Part 2 with @twj1974 @VijayKunadian and @jedicath to moderate the chat! 🗓️July 10th 5:00 PM Paris time

I like it so much, I just had to share it @AGIKinterv @DGK_org @PCRonline #cardiotwitter #cardiology @ESCardioNews